©µ¿ð±µºØ²Ä¤G¾¯¬Ì] ±M®a¼~µLªk¥R¤ÀÀò§K¬Ì¤O
¡i©ú³ø±M°T¡j¦b½÷·ç¤½¥q«Å¥¬¬Ì]¨ÑÀ³±N¥X²{µu´Á©µ½w¤§«á¡A¥[®³¤jªº¤@¨Ç¬Ù¥÷¨M©w¡A±À¿ð²Ä¤G¾¯¬Ì]ªºª`®g®É¶¡¡C¤@¨Ç±M®a»{¬°³o¬O¡u«_ÀIªº¤èªk¡v¡A¬Æ¦Ü¥i¥HºÙ±o¤W¬O¡u½ä³Õ¡v¡C¦ý¤]¦³ªº±M®a»{¬°ÂX¤j±µºØÂл\±¡A«©ó¾d©T¤w±µºØ¤H¸sªº§K¬Ì¤O¡C
½÷·ç¬Ì]ªº«ü©w¾¯¶q¶¡¹j®É¶¡¬°21¤Ñ¡A²ö¼w¯Ç¬Ì]ªº¶¡¹j®É¶¡¬°28¤Ñ¡C
¦w¬Ù¬F©²¤W©P¤»«Å¥¬¡A¤w±µ¨ü¹L²Ä¤@¾¯½÷·ç¬Ì]ªºªø´ÁÅ@²z°|°|¤Í¡Bû¤u©M°ò¥»Å@²z¤Hû¡A±N¦b21¦Ü27¤Ñ¤º±µ¨ü²Ä¤G¾¯ª`®g¡C¦Ó¨ä¥L©Ò¦³ªº¤H¡A«hn¦b¤T©P¦Ü¦b42¤Ñ¤§¤º±µ¨ü²Ä¤G¾¯¡C
±M®a̾á¤ß¡A³o¥i¯à·|¹ï¬Ì]ªº®Ä¤O²£¥Í¼vÅT¡C
¦hÛ¦h¤j¾Ç§K¬Ì¾Ç±Ð±Â°¨¤B(Alberto Martin)³Õ¤h»¡¡G¡u³o¨Ç¤H¤¤¦³«Ü¤j¤@³¡¤À¥i¯àµLªk¥R¤ÀÀò±o§K¬Ì¤O¡A±q¦Ó·|®ö¶O³\¦h¾¯¶q¡C¡v
«w¬ü¹ySt. Joseph¡¦s HealthcareÂå°|¶Ç¬V¯fÂå¥ÍZain Chaglaªí¥Ü¡G¡u¶¡¹j®É¶¡·Uªø¡A·ÀI´N·U°ª¡A¥i¯àµLªkÀò±o§¹¥þªº§K¬Ì¤ÏÀ³¡C¡v
¦ý¥Ñ©ó³o¬O¤@Ó¨S¦³¨¬°÷¼Æ¾Úªº¹êÅç¡AChagla©MMartin³£ªí¥Ü¡A©µ¿ðªº½T¤Á¼vÅT©|¤£²M·¡¡C
¥@¬É½Ã¥Í²Õ´(WHO)«Øij¡A¦b¬Ì]¨ÑÀ³µu¯Êªº±¡ªp¤U¡A²Ä¤G¾¯½÷·ç¬Ì]¥i¥H©µ¿ð¦Ü6¶g©Î42¤Ñ¡A³o¤]¬O¥[®³¤j°ê®a±µºØ¬Ì]ÅU°Ý¤p²Õ(The National Advisory Committee on Immunization, NACI) ±ÀÂ˪º´Á¡C
®Ú¾ÚNACIªº¸ê®Æ¡A¥Ø«eÁÙ¨S¦³¦³Ãö¨â¦¸µ¹ÃĤ§¶¡ªº³Ì¤j¶¡¹j¡A©Î¬Ì]ªº¤¤¡Bªø´ÁÀø®Äªº¼Æ¾Ú¡CNACI±M®aªí¥Ü¡A±N²Ä¤G¦¸ª`®gªº®É¶¡±À¿ð¨ì6¶g¡A¦Ó¤£¬O¤T¨ì¥|©P¡A¥i¥H¨Ï§ó¦h¤H§ó§Ö¦aÀò±o°w¹ï¯f¬rªº¬YºØ«OÅ@¡C
¦ýChagla¾á¤ß¡A¦³¥i¯àµLªk±q¬Ì]¤¤Àò±o¾A·íªº¤ÏÀ³©Mªø´Á§K¬Ì¡C¦Û±q12¤ë¤¤¦¯¶}©l¦b¥þ°êS³ò±À¼s¥H¨Ó¡A¦U¬Ù¤@ª½¦bÅv¿Å¤À°tªº¤£¦P¤è®×¡A¥H¤Î¬O§_n«O¯d²Ä¤G¾¯¬Ì]¡A¦]¬°¨Ó¦Û½÷·ç©M²ö¼w¯Çªº¬Ì]¨ÑÀ³«D±`½wºC¡C
ªüº¸§B¹F¬Ùªº¬Ì]§Y±N¥ÎºÉ¡A¬Ù©²¤w°±¤î²Ä¤@¾¯ªº¹w¬ùª`®g¡C
·í¨ÑÀ³Ã줣éw®É¡A¤j¦h¼Æ±M®a³£»{¬°¡AÀ³¸ÓÀu¥ý¦Ò¼{µ¹¦Ñ¤H©Mªø´ÁÅ@²z°|°|¤Í«ö®Éª`®g¨â¾¯¡C
®Ú¾Ú¦hÛ¦h¤j¾Ç¬ã¨s¤Hûªº³Ì·s«Ø¼Ò¼Æ¾Ú¡A²{¦b´N±N¤j¦h¼Æªº¬Ì]µ¹¤Hª`®g¡A¦Ó¤£¬O±N¨ä¤¤¤@¥b¯d¤U¨Ó§@²Ä¤G¾¯¨Ï¥Î¡A¥i¥H¹w¨¾¤j¶q·sªº¦³¯gª¬·P¬V¡C
¦hÛ¦h¤j¾Ç¶Ç¬V¯f±M®a¯Z¯Ç¦N(Anna Banerji)Âå¥Í»¡¡A³Ì¦n¬O±N²Ä¤@¾¯¬Ì]ºÉ§Öµ¹ºÉ¥i¯à¦hªº¤H±µºØ¡A¦Ó¤£¬O¦bµu¯Ê®É«O¯d²Ä¤G¾¯¬Ì]¡C
¡u¦pªG³Ì²×¥Ø¼Ð¬O®¾±Ï¥Í©R¨Ã«OÅ@¦í°|©M¯Ü®zªº¤H¸s¡A¨º»ò³Ì¦n±N¬Ì]±µºØµ¹©Ò¦³°ª·ÀI¤H¸s¡A¨Ò¦pªø´ÁÅ@²z°|°|¤Í¡A¦Ó¤£¬O¨ä¤¤ªº¤@¥b¡C¡v
®Ú¾ÚÁ{þH¸ÕÅ窺¼Æ¾Ú¡A½÷·çªº¬Ì]¦³®Ä²v¬°95%¡A¥i¦bº¦¸±µºØ«áªº12¤Ñ¤§¤º´£¨Ñ³¡¤À«OÅ@¡C
³Á¦cº¸¤j¾Ç¶Ç¬V¯f±M®aÝÂå¾Ç·L¥Íª«¾Ç®a¤å»®(Donald Vinh)»¡¡A³oºØ«OÅ@¦Ü¤Ö¥i¥H«ùÄò¨âÓ¤ë¡AµM«á»Ýn²Ä¤G¾¯¤~¯à¹F¨ì¬Ì]ªº¥þ³¡¼ç¤O¡C
¼Æ¾ÚÁÙÅã¥Ü¡A21¤Ñ«áµ¹¤©²Ä¤G¾¯¥i¼W±j§K¬Ì¤ÏÀ³¡A¦b²Ä¤G¦¸¾¯«á¤@©P¶}©l´£¨Ñ«OÅ@¡C
¤å»®»¡¡A²ö¼w¯Çªº¬Ì]¤]»Ýn²Ä¤G¦¸ª`®g¡A¨Ã¥B¤w¸gÅã¥Ü¥X94%ªº¦³®Ä²v¡A¥i¥H¦b²Ä¤@¦¸ª`®g«áªº¨â©P¤º´£°ª«OÅ@©Ê§ÜÅé¤ô¥¡A¨Ã«ùÄò¦Ü¤Ö¤TÓ¤ë¡C